Bamforth–Lazarus syndrome
Bamforth–Lazarus syndrome is a rare congenital disorder that affects the thyroid gland. It is characterized by thyroid dysgenesis, which is the underdevelopment or complete absence of the thyroid gland. This condition is caused by mutations in the FOXE1 gene.
Symptoms
The symptoms of Bamforth–Lazarus syndrome are primarily related to hypothyroidism, which is a deficiency of thyroid hormones. These may include fatigue, weight gain, depression, and cold intolerance. In severe cases, the condition can lead to cretinism, a condition characterized by physical and mental retardation.
Causes
Bamforth–Lazarus syndrome is caused by mutations in the FOXE1 gene. This gene provides instructions for making a protein that is involved in the development of the thyroid gland. Mutations in the FOXE1 gene disrupt the normal development of the thyroid gland, leading to the symptoms of Bamforth–Lazarus syndrome.
Diagnosis
The diagnosis of Bamforth–Lazarus syndrome is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests may include blood tests to measure levels of thyroid hormones, imaging studies to visualize the thyroid gland, and genetic testing to identify mutations in the FOXE1 gene.
Treatment
The treatment of Bamforth–Lazarus syndrome is directed toward the specific symptoms that are apparent in each individual. Treatment may include thyroid hormone replacement therapy to manage the symptoms of hypothyroidism. In some cases, surgery may be necessary to correct physical abnormalities associated with the condition.
Prognosis
The long-term outlook for individuals with Bamforth–Lazarus syndrome varies. With early diagnosis and appropriate treatment, most individuals with the condition can lead normal, healthy lives. However, if left untreated, the condition can lead to serious complications, including mental retardation and physical abnormalities.
See also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


